ReachMD

Episodes 1-15 of 92

• • 

    

    Peter Buch, MD, FACG, AGAF, FACP

    Peer

  • 

    

    Lawrence Schiller, MD, FAP, FACG

    Peer

  0

  

  RestartResume

  Is It Chronic Diarrhea Or Irritable Bowel Syndrome with Diarrhea?

• • 

    

    Ivy Ka Man Law, PhD

    Peer

  6

  

  RestartResume

  A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice

• • 

    

    Abdullah Abdussalam, MD

    Peer

  13

  

  RestartResume

  Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease

• • 

    

    Anish Patel, DO, FACG

    Peer

  10

  

  RestartResume

  Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease

• • 

    

    Robin Dalal, MD

    Peer

  5

  

  RestartResume

  Improving the Quality of Inpatient Ulcerative Colitis Management

• • 

    

    Millie D. Long, MD, MPH

    Peer

  8

  

  RestartResume

  The Evolution of Treatment Options in Crohn’s Disease

  0.25 credits

• • 

    

    Thomas Ullman, MD

    Peer

  • 

    

    Juli Tomaino, MD

    Peer

  • 

    

    Sarah Yim, MD

    Peer

  9

  

  RestartResume

  Assessing Biosimilar Medications for Inflammatory Bowel Diseases

• • 

    

    Jennifer Caudle, DO

    Peer

  6

  

  RestartResume

  A Pre-Teen’s Perspective on Living with IBD

• • 

    

    Louis J Cohen, MD

    Peer

  12

  

  RestartResume

  Does Obesity Play a Role in the History of Inflammatory Bowel Diseases?

• • 

    

    Alka Goyal, MD

    Peer

  10

  

  RestartResume

  Assessing the Correlation Between Perianal Fistula Healing & Trough Levels of Infliximab in Children with IBD

• • 

    

    Gary R. Lichtenstein, MD

    Peer

  • 

    

    Marla Dubinsky, MD

    Peer

  10

  

  RestartResume

  Crohn’s & Colitis Congress: Making Sense of IBD Care Guidelines

• • 

    

    Shail Govani, MD, MSc

    Peer

  6

  

  RestartResume

  Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis

• • 

    

    Yash Mittal, MD

    Peer

  8

  

  RestartResume

  Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography

• • 

    

    Barnett Mennen, MD

    Peer

  14

  

  RestartResume

  Making Dollars and 'Sense' of Physician Quality Reporting Systems in Gastroenterology

• • 

    

    Barnett Mennen, MD

    Peer

  28

  

  RestartResume

  Can Dietary Zinc Help Treat and Prevent Inflammatory Bowel Disease?

• 1
• 2
• 3
• …
• 6
• 7
• Next